Month: May 2020

SIKA PRODUZIERT SCHUTZMASKEN FÜR MITARBEITENDE UND KUNDENSika hat in Frankreich mit der Produktion von Atemschutzmasken begonnen. Nach der Herstellung von Handdesinfektionsmittel in mehr als 15 Sika Ländergesellschaften seit März 2020 werden nun auch Schutzmasken für Mitarbeitende, Kunden und andere Interessenten gefertigt. Die Produktionskapazität umfasst 15’000 Masken täglich.Sika hat im Werk in Les Salles du Gardon im Süden Frankreichs die Produktion von Atemschutzmasken aufgenommen, die nahezu vollständig mit Sika Produkten hergestellt werden. Knapp 50’000 Masken wurden bereits produziert – Bestellungen für mehr als 165’000 Masken liegen vor. Eingesetzt werden Schutzlagen auf Basis von Polyester, die bei der Abdichtung von Dächern zwischen Membrane und Unterkonstruktion eingesetzt werden sowie Dichtstoffe auf Silikonbasis, die in...

ROTTERDAM, The Netherlands (19 May 2020, 07:00 CET) – IMCD N.V. (“IMCD”), a leading distributor of speciality chemicals and food ingredients, today announces the publication of the convocation and agenda for its Annual General Meeting of shareholders (“AGM”), which will be held on Tuesday 30 June 2020 at 10:30 CET in Rotterdam, The Netherlands.The convocation and agenda for the AGM as well as the proxy form, are available on the Investors’ section of IMCD’s website at: https://www.imcdgroup.com/investors/corporate-governance/general-meeting-shareholders.Please find attached the full press release.AttachmentPRESS RELEASE_IMCD publishes convocation for its upcoming Annual General Meeting

Zolgensma® (onasemnogene abeparvovec) is conditionally approved in Europe for the treatment of patients with spinal muscular atrophy (SMA) and a clinical diagnosis of SMA Type 1; or SMA patients with up to three copies of the SMN2 gene Zolgensma has demonstrated significant and clinically meaningful therapeutic benefit in pre-symptomatic and symptomatic SMA, including prolonged event-free survival and achievement of motor milestones unseen in natural history of the disease and to date, sustained for 5 years post-dosing   Immediate access to Zolgensma, aligned to the label, is available in France through the ATU framework and expected shortly in Germany AveXis in discussions with EU governments and reimbursement agencies to agree on terms of innovative “Day One” access program to enable rapid access in all EU countries given urgent need...

SalMar ASA reported an Operational EBIT of NOK 1,065 million for the first quarter of 2020. This is the highest ever achieved in the company’s history. In the same period of 2019, Operational EBIT came to NOK 806 million.“For the SalMar Group, the first quarter was very good. We posted the highest ever Operational EBIT in the company’s history, achieved through strong underlying operations, high volumes and good prices. Central Norway in particular distinguished itself through solid performance in the quarter,” says SalMar’s CEO Gustav Witzøe.Gross operating revenues came to just over NOK 3.6 billion for the quarter, up 22 per cent on the same quarter of 2019. SalMar harvested 40,000 tonnes in the first quarter, up from 35,500 tonnes in the corresponding period last year. Operational EBIT per kg came to NOK 26.61 for the first quarter,...

SalMar ASA leverte et rekordhøyt operasjonelt driftsresultat (EBIT) på 1 065 millioner kroner i første kvartal 2020, opp fra 806 millioner kroner i samme periode i 2019.– Første kvartal ble et meget godt kvartal for SalMar-konsernet. Vi leverer det høyeste operasjonelle driftsresultatet i selskapets historie, drevet av god underliggende drift, høye volumer og gode priser. Virksomheten i Midt-Norge utmerker seg særlig med solid drift i kvartalet, sier konsernsjef Gustav Witzøe i SalMar.Samlede driftsinntekter utgjorde i overkant av 3,6 milliarder kroner i kvartalet, en økning på 22 prosent fra første kvartal i 2019. SalMar slaktet 40 000 tonn i kvartalet, opp fra 35 500 tonn i tilsvarende periode i fjor. Det operasjonelle driftsresultatet per kilo endte på 26,61 kroner per kilo i første kvartal i år, opp fra 22,71 kroner per kilo...

VANCOUVER, British Columbia, May 19, 2020 (GLOBE NEWSWIRE) — Bolt Metals Corp. (CSE: BOLT) (FRANKFURT: NXFE) (OTCQB: PCRCF) (the “Company” or “Bolt Metals”), an Indonesia-based company focused on developing battery mineral projects in the Asia‐Pacific region, is pleased to report Indonesia’s parliament has passed revisions to its mining law aimed at removing red tape and attracting investment into the sector.A leader in nickel production, Indonesia continues to update its national strategy and laws governing the minerals and mining sector, supporting their mandate to lead the world in battery metals and cathode material production capacity.On May 8, 2020 BloombergNEF stated, “Indonesia’s desire to move up the value chain and leverage its nickel wealth into becoming an EV and battery manufacturing hub is supported by the fact that...

What you need to know:86 percent of data breaches for financial gain – up from 71 percent in 2019Cloud-based data under attack – web application attacks double to 43 percent67 percent of breaches caused by credential theft, errors and social attacksClearly identified cyber-breach pathways enable a “Defender Advantage” in the fight against cyber-crimeOn-going patching successful – fewer than 1 in 20 breaches exploit vulnerabilitiesReport analyzes 32,002 security incidents and 3,950 confirmed breaches from 81 global contributors from 81 countriesNEW YORK, May 19, 2020 (GLOBE NEWSWIRE) — The Verizon Business 2020 Data Breach Investigations Report (2020 DBIR) shows that financial gain remains the key driver for cybercrime with nearly nine in 10 (86 percent) breaches investigated financially-driven. The vast majority of breaches...

PITTSBURGH, May 18, 2020 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (Nasdaq: KRYS) (the “Company”), a gene therapy company developing a new class of transformative medicines to treat diseases caused by gene or protein dysfunction, today announced that it has priced the previously announced underwritten public offering of 2,275,000 shares of its common stock, at a public offering price of $55.00 per share. The Company granted the underwriters a 30-day option to purchase up to an additional 341,250 shares of its common stock. The gross proceeds to the Company from this offering are expected to be approximately $125.1 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company. The offering is expected to close on or about May 21, 2020, subject to satisfaction of customary...

SAN DIEGO, May 18, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (Nasdaq: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced the pricing of its previously announced underwritten public offering of 5,416,667 shares of its common stock at a price to the public of $60.00 per share. The gross proceeds to Turning Point from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Turning Point, are expected to be approximately $325.0 million. In addition, Turning Point has granted the underwriters a 30-day option to purchase up to an additional 812,500 shares of common stock. The offering is expected to close on or about May 21, 2020, subject to satisfaction of customary closing conditions.Goldman...

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.TORONTO, May 18, 2020 (GLOBE NEWSWIRE) — Buzz Capital Inc. (TSXV: BUZ.P) (“Buzz Capital” or the “Corporation“), a capital pool company listed on the TSX Venture Exchange (the “Exchange“), is pleased to announce that it has signed a letter of intent dated May 8, 2020 (the “Letter of Intent“) with Novamind Ventures Inc., an Ontario corporation, (“Novamind”) to complete a business combination by way of a transaction that will constitute a reverse takeover of Buzz Capital by Novamind. The proposed transaction is intended to constitute an arm’s length qualifying transaction (the “Qualifying Transaction“)...